Diversification of edaravone via palladium-catalyzed hydrazine cross-coupling: Applications against protein misfolding and oligomerization of beta-amyloid
摘要:
N-Aryl derivatives of edaravone were identified as potentially effective small molecule inhibitors of tau and beta-amyloid aggregation in the context of developing disease-modifying therapeutics for Alzheimer's disease (AD). Palladium-catalyzed hydrazine monoarylation protocols were then employed as an expedient means of preparing a focused library of 21 edaravone derivatives featuring varied N-aryl substitution, thereby enabling structure-activity relationship (SAR) studies. On the basis of data obtained from two functional biochemical assays examining the effect of edaravone derivatives on both fibril and oligomer formation, it was determined that derivatives featuring an N-biaryl motif were four-fold more potent than edaravone. (C) 2015 Elsevier Ltd. All rights reserved.
Electrochemical synthesis of versatile ammonium oxides under metal catalyst-, exogenous-oxidant-, and exogenous-electrolyte-free conditions
作者:Yong Yuan、Liang-Sen Li、Lin Zhang、Feng Wang、Lin Jiang、Lin Zuo、Qi Wang、Jian-Guo Hu、Aiwen Lei
DOI:10.1039/d1cc00486g
日期:——
An electrochemical oxidative cross-coupling reaction between 2.5-substituted-pyrazolin-5-ones and ammoniumthiocyanate has been developed, which resulted in a series of unprecedented cross-coupling products under metal catalyst-, exogenous-oxidant-, and exogenous-electrolyte-free conditions. It is worth noting that since the resulting cross-coupling products are nearly insoluble in MeCN, the pure product
Regioselectivity Switch in Palladium‐Catalyzed Allenylic Cycloadditions of Allenic Esters: [4+1] or [4+3] Cycloaddition/Cross‐Coupling
作者:Long Li、Pengfei Luo、Yuhua Deng、Zhihui Shao
DOI:10.1002/anie.201901511
日期:2019.3.26
The first Pd‐catalyzed asymmetric allenylic [4+1] cycloaddition was successfully developed. Alternatively, tuning the Pd catalyst switched the reactivity toward an unprecedented [4+3] cycloaddition/cross‐coupling. Ligands play a vital role in controlling the reaction pathway, allowing highly selective access to different products from identical substrates. Biological evaluation of the obtained compounds
Zinc chloride catalyzed stereoselective construction of spiropyrazolone tetrahydroquinolines via tandem [1,5]-hydride shift/cyclization sequence
作者:Tuan Zhao、Huanrui Zhang、Longchen Cui、Jingping Qu、Baomin Wang
DOI:10.1039/c5ra18471a
日期:——
A zinc chloride catalyzed tandem 1,5-hydride shift/cyclization process to form spiropyrazolone terahydroquinoline derivatives is developed. A series of new spiropyrazolone derivatives were obtained in good to high yields with good to excellent diastereoselectivities (up to 95% yield, >95 : 5 dr). Additionally, the spiropyrazolone derivatives could be converted into the corresponding novel spriopyrazolines
Rhodium‐Catalyzed [4+2] Annulation of N‐Aryl Pyrazolones with Diazo Compounds To Access Pyrazolone‐Fused Cinnolines
作者:Chih‐Yu Lin、Wan‐Wen Huang、Ying‐Ti Huang、Sandip Dhole、Chung‐Ming Sun
DOI:10.1002/ejoc.202101005
日期:2021.9.21
An efficientsynthesis of novel dinitrogen-fused heterocycles, such as pyrazolo[1,2-a]cinnoline derivatives, has been accomplished by the rhodium(III)-catalyzed reaction of N-arylpyrazol-5-ones with diazo compounds. This reaction proceeds through a cascade C−H activation/intramolecular cyclization under mild reaction conditions and features a broad substrate scope.
新型二氮稠合杂环的有效合成,例如吡唑并[1,2- a ]肉啉衍生物,已通过铑(III)催化的N-芳基吡唑-5-酮与重氮化合物的反应完成。该反应在温和的反应条件下通过级联 CH 活化/分子内环化进行,具有广泛的底物范围。
One-pot cascade synthesis of N-methoxyisoquinolinediones via Rh(<scp>iii</scp>)-catalyzed carbenoid insertion C–H activation/cyclization
作者:Jingjing Shi、Jie Zhou、Yunnan Yan、Jinlong Jia、Xuelei Liu、Huacan Song、H. Eric Xu、Wei Yi
DOI:10.1039/c4cc08407a
日期:——
new, mild and versatile method for one-pot cascade synthesis of diverse N-methoxyisoquinolinediones via Rh(III)-catalyzedregioselectivecarbenoidinsertionC-H activation/cyclization of N-methoxybenzamides with alpha-diazotized Meldrum'sacid has been achieved. Extension of the developed Rh(III) catalysis for building new analogs of the marketed drug Edaravone has also been demonstrated.